Language selection

Search

Details for: PREVNAR 20

Company: PFIZER CANADA ULC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02527049PREVNAR 20PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F; CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 4.4 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 2.2 MCG / 0.5 ML; 51 MCG / 0.5 MLSUSPENSIONINTRAMUSCULAR
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Regulatory Decision Summary

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: